Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update

It has been consistently demonstrated that circulating lipids and particularly low-density lipoprotein cholesterol (LDL-C) play a significant role in the development of coronary artery disease (CAD). Several trials have been focused on the reduction of LDL-C values in order to interfere with atherot...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fabiana Lucà, Fabrizio Oliva, Carmelo Massimiliano Rao, Maurizio Giuseppe Abrignani, Antonio Francesco Amico, Stefania Angela Di Fusco, Giorgio Caretta, Irene Di Matteo, Concetta Di Nora, Anna Pilleri, Roberto Ceravolo, Roberta Rossini, Carmine Riccio, Massimo Grimaldi, Furio Colivicchi, Michele Massimo Gulizia
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-08-01
Col·lecció:	Metabolites
Matèries:	lipid-lowering therapy (LLT) post-acute-coronary-syndrome PCSK9 inhibitors inclisiran statins ezetimibe
Accés en línia:	https://www.mdpi.com/2218-1989/13/8/916
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!